FAKTOR OPTIONSSCHEIN - BIOMERIEUX Share Price

Certificat

DE000GG008R4

Market Closed - BOERSE MUENCHEN 11:55:25 17/05/2024 pm IST
2.36 EUR +2.61% Intraday chart for FAKTOR OPTIONSSCHEIN - BIOMERIEUX
Current month+46.58%
1 month+35.63%
Date Price Change
17/24/17 2.36 +2.61%
16/24/16 2.3 -6.50%
15/24/15 2.46 0.00%
14/24/14 2.46 +21.78%
13/24/13 2.02 +25.47%

Real-time BOERSE MUENCHEN

Last update May 17, 2024 at 11:55 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying BIOMÉRIEUX
Issuer Goldman Sachs
WKN GG008R
ISINDE000GG008R4
Date issued 21/11/2023
Strike 105.6
Maturity Unlimited
Parity 4.14 : 1
Emission price 9.99
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 9.77
Lowest since issue 0.97
Spread 0.7
Spread %24.65%

Company Profile

bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows: - medical applications (84.4%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors; - industrial applications (15.6%). The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services. Net sales are distributed geographically as follows: Europe/Middle East/Africa (32.4%), North America (44.1), Asia/Pacific (17.3%) and Latin America (6.2%).
Sector
-
More about the company

Ratings for bioMérieux

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: bioMérieux

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
95.9 EUR
Average target price
113.4 EUR
Spread / Average Target
+18.25%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW